The discovery that loss of neuronatin can promote UCP1 induction is a potentially important discovery, and more detailed analysis of neuronatin biochemistry is required before it can be proposed that manipulation of neuronatin represents a point for therapeutic intervention in human obesity. This evidence concerns the gene NNAT and obesity due to melanocortin 4 receptor deficiency.